Life Expectancy of Children with Perinatal HIV in High-Income Countries
With early diagnosis and modern antiretroviral therapy (ART), children with perinatally acquired HIV in industrialized nations now have near-normal life expectancy.
Key Advances
- Universal prenatal HIV screening → maternal ART → vertical transmission <1%.
- Early infant diagnosis (PCR at birth, 2–4 weeks, 4–6 months).
- Pediatric ART initiation (within weeks of birth) → immune preservation, viral suppression.
- Improved formulations: Palatable, once-daily, integrase inhibitor-based regimens.
- Comprehensive care: Growth monitoring, neurocognitive support, vaccination, transition to adult care.
Outcomes
- Survival into adulthood >95% in treated cohorts.
- Long-term complications: metabolic (lipodystrophy, insulin resistance), bone (low BMD), renal (TDF), neurocognitive.
- Adherence challenges in adolescence.
Global Disparity
In resource-limited settings, access to early ART remains suboptimal; mortality higher. WHO "treat all" guidelines aim to close gap.
HIV & AIDS - Related Articles
- HIV Transmission Risk: Self-Injury and Natural Water Sources
- HIV vs. Other STDs: Prevalence Ranking & Risk Context
- Condom Effectiveness: Limitations and Proper Use Tips
- Understanding AIDS: Facts, Transmission, and Global Impact
- Understanding AIDS: A Comprehensive Overview of HIV and Immune Deficiency
- HIV Transmission Risk: Male to Female - Understanding the Chances
- HIV & Opportunistic Infections: Increased Risk & Common Conditions
